List of works - Stéphanie Raymond

Accurate quantification of CXCR4-using HIV-1 variants by Illumina deep-sequencing

article

Algorithm-based prediction of HIV-1 subtype D coreceptor use

scientific article published on 26 June 2013

Analytical sensitivity of three real-time PCR assays for measuring subtype B HIV-1 RNA.

scientific article published on 11 January 2013

Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

scientific article published on 25 October 2014

Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma

scientific article published on 2 May 2017

Brief Report: HIV-1 Tropism During Primary Infections in France: 1996-2014.

scientific article

CCR5 structural plasticity shapes HIV-1 phenotypic properties

article

CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression

scientific article published in September 2010

Characterization of CXCR4-using HIV-1 during primary infection by ultra-deep pyrosequencing.

scientific article published on 18 July 2013

Comment on: High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists

scientific article published on 16 June 2010

Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus.

scientific article published on 28 August 2016

Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropism

scientific article

Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism

scientific article published in September 2008

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

scientific article published on 3 January 2015

Detection and quantification of HIV-1 RNA with a fully automated transcription-mediated-amplification assay.

scientific article published on 5 October 2016

Determining seminal plasma human immunodeficiency virus type 1 load in the context of efficient highly active antiretroviral therapy.

scientific article published on 29 July 2009

Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage

article

Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)

scientific article published on 01 August 2018

Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens

scientific article published on 06 July 2020

Evaluation of the QIAsymphony™ SP and Artus™ RealTime extraction-quantification systems for measuring HIV-1 virus load

scientific article published on 23 September 2011

Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study

scientific article

Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy

scientific article published on 19 May 2014

Frequency of CXCR4-using viruses in primary HIV-1 infections using ultra-deep pyrosequencing

article

Genotypic prediction of HIV-1 CRF01-AE tropism.

scientific article published on 5 December 2012

Genotypic prediction of HIV-1 subtype D tropism

scientific article

Genotypic prediction of human immunodeficiency virus type 1 CRF02-AG tropism.

scientific article published on 13 May 2009

HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc

scientific article published on 11 June 2015

HIV-1 dynamics and coreceptor usage in Maraviroc-treated patients with ongoing replication

scientific article published on 3 December 2012

HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy

scientific article published on 01 March 2019

HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.

scientific article published on 12 February 2018

HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes

scientific article published on 25 November 2012

HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.

scientific article

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies

scientific article published on 26 February 2015

HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients

scientific article

Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen

scientific article published on 13 December 2017

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

scientific article published on 01 March 2019

Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropism

scientific article

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

article

Long-term evolution of transmitted CXCR4-using HIV-1 under effective antiretroviral therapy

scientific article published on 01 November 2019

Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infection

scientific article

Minority resistant HIV-1 variants and the response to first-line NNRTI therapy

scientific article published on 20 November 2014

Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection.

scientific article published on 20 July 2012

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

scientific article

No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV-infected patients on suppressive maraviroc therapy.

scientific article

Patterns of residual HIV-1 RNA shedding in the seminal plasma of patients on effective antiretroviral therapy.

scientific article published on 8 September 2017

Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene

article

Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use

scientific article

Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance

scientific article published on 26 November 2019

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

scientific article published on 12 January 2018

Phenotyping methods for determining HIV tropism and applications in clinical settings

scientific article published on September 2012

Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism

scientific article

Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses

scientific article published in February 2010

Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence.

scientific article

Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients

scientific article published on 01 May 2019

Shift in phenotypic susceptibility suggests a competition mechanism in a case of acquired resistance to maraviroc

scientific article published in June 2010

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

scientific article published on 01 May 2019

THETA: a new genotypic approach for predicting HIV-1 CRF02-AG coreceptor usage

scientific article published on 01 January 2020

Virological failure of patients on maraviroc-based antiretroviral therapy

scientific article published on 19 February 2015

X4 tropic multi-drug resistant quasi-species detected at the time of primary HIV-1 infection remain exclusive or at least dominant far from PHI

scientific article

List of works by Stéphanie Raymond

Accurate quantification of CXCR4-using HIV-1 variants by Illumina deep-sequencing

Algorithm-based prediction of HIV-1 subtype D coreceptor use

Analytical sensitivity of three real-time PCR assays for measuring subtype B HIV-1 RNA.

Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma

Brief Report: HIV-1 Tropism During Primary Infections in France: 1996-2014.

CCR5 structural plasticity shapes HIV-1 phenotypic properties

CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression

Characterization of CXCR4-using HIV-1 during primary infection by ultra-deep pyrosequencing.

Comment on: High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists

Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus.

Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropism

Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

Detection and quantification of HIV-1 RNA with a fully automated transcription-mediated-amplification assay.

Determining seminal plasma human immunodeficiency virus type 1 load in the context of efficient highly active antiretroviral therapy.

Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage

Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)

Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens

Evaluation of the QIAsymphony™ SP and Artus™ RealTime extraction-quantification systems for measuring HIV-1 virus load

Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study

Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy

Frequency of CXCR4-using viruses in primary HIV-1 infections using ultra-deep pyrosequencing

Genotypic prediction of HIV-1 CRF01-AE tropism.

Genotypic prediction of HIV-1 subtype D tropism

Genotypic prediction of human immunodeficiency virus type 1 CRF02-AG tropism.

HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc

HIV-1 dynamics and coreceptor usage in Maraviroc-treated patients with ongoing replication

HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy

HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.

HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes

HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies

HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients

Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropism

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Long-term evolution of transmitted CXCR4-using HIV-1 under effective antiretroviral therapy

Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infection

Minority resistant HIV-1 variants and the response to first-line NNRTI therapy

Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection.

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV-infected patients on suppressive maraviroc therapy.

Patterns of residual HIV-1 RNA shedding in the seminal plasma of patients on effective antiretroviral therapy.

Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene

Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use

Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

Phenotyping methods for determining HIV tropism and applications in clinical settings

Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism

Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses

Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence.

Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients

Shift in phenotypic susceptibility suggests a competition mechanism in a case of acquired resistance to maraviroc

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

THETA: a new genotypic approach for predicting HIV-1 CRF02-AG coreceptor usage

Virological failure of patients on maraviroc-based antiretroviral therapy

X4 tropic multi-drug resistant quasi-species detected at the time of primary HIV-1 infection remain exclusive or at least dominant far from PHI